Related Experiment Video
Updated: Dec 19, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2
Yun Wang1, Chang-Feng Li2, Li-Bo Sun3
1Department of Internal Medicine, Liver and Biliary Disease Hospital of Jilin Province, Changchun, Jilin, China.
Abstract:
Hepatocellular carcinoma (HCC) remains a lethal cancer type for both males and females. MicroRNAs (miRNAs) contribute to the initiation, development and metastasis of cancer. Although several miRNAs have been identified as drivers or suppressors of HCC, the molecular mechanisms of many miRNAs have not been investigated. Currently, we discovered that miR-4270-5p was a significantly downregulated miRNA in HCC. We revealed that miR-4270-5p overexpression inhibited cell proliferation and invasion of HCC cells. The data manifested that miR-4270-5p directly targeted SATB2, a key regulator of epithelial mesenchymal transition (EMT), in HCC cells and reversed the EMT process. The rescue experiments suggested that SATB2 overexpression reversed the biological function of miR-4270-5p in HCC cells. Clinical data indicated that SATB2 expression was negatively correlated with miR-4270-5p levels in HCC patients. Our findings provided potential targets for prognosis and treatment of patients with HCC.
Insights
MicroRNA miR-4270-5p, a tumor suppressor, is downregulated in hepatocellular carcinoma (HCC). Its restoration inhibits HCC cell growth and metastasis by targeting SATB2 and reversing epithelial mesenchymal transition (EMT).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern with limited treatment options.
- MicroRNAs (miRNAs) play crucial roles in cancer development, including HCC, but their specific functions and targets are not fully elucidated.
- Understanding the molecular mechanisms of miRNA regulation in HCC is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of miR-4270-5p in hepatocellular carcinoma (HCC).
- To identify the molecular targets and mechanisms underlying the function of miR-4270-5p in HCC.
- To explore the potential of miR-4270-5p as a therapeutic target for HCC.
Main Methods:
- Quantitative real-time PCR to assess miR-4270-5p expression in HCC tissues and cell lines.
- Cell proliferation and invasion assays to evaluate the functional impact of miR-4270-5p.
- Luciferase reporter assays and Western blotting to confirm direct targeting of SATB2 by miR-4270-5p.
- Rescue experiments to validate the role of SATB2 in mediating miR-4270-5p's function.
- Correlation analysis of clinical data to assess the relationship between miR-4270-5p and SATB2 expression in HCC patients.
Main Results:
- miR-4270-5p was found to be significantly downregulated in HCC.
- Overexpression of miR-4270-5p suppressed HCC cell proliferation and invasion.
- miR-4270-5p directly targets SATB2, a key regulator of epithelial-mesenchymal transition (EMT).
- miR-4270-5p overexpression reversed the EMT process in HCC cells.
- SATB2 overexpression rescued the inhibitory effects of miR-4270-5p on HCC cells.
- Clinical data showed a negative correlation between miR-4270-5p and SATB2 expression in HCC patients.
Conclusions:
- miR-4270-5p acts as a tumor suppressor in hepatocellular carcinoma.
- The miR-4270-5p/SATB2 axis is a critical regulator of EMT and progression in HCC.
- miR-4270-5p represents a potential biomarker for prognosis and a therapeutic target for HCC treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

